Table 1.
Migraine subject characteristics. M: male; F: female; B: bilateral; L: left; R: right; OCP: oral contraceptive pill
| Subject | Age | Sex | Years suffering | Pain side | Aura | Frequency (per month) | Intensity (0–5) | Medication taken during migraine | Daily medication |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 31 | F | 25 | R | Y | > 3 | 3–4 | paracetamol | – |
| 2 | 53 | M | 15 | B | N | > 3 | 4 | ibuprofen, paracetamol | – |
| 3 | 24 | F | 20 | B | N | > 3 | 4 | ibuprofen, paracetamol | OCP, budesonide/formoterol |
| 4 | 26 | F | 12 | R | N | 2 | 3–4 | ibuprofen | OCP |
| 5 | 27 | F | 12 | R | Y | 1 | 4 | ibuprofen | OCP |
| 6 | 23 | F | 4 | R | N | > 3 | 4 | triptan | OCP, metformin hydrochloride |
| 7 | 25 | F | 12 | L | N | > 3 | 3 | aspirin, rizatriptan | desvenlafaxine |
| 8 | 21 | F | 1.5 | L | N | > 3 | 3 | ibuprofen, paracetamol, codeine | OCP |
| 9 | 26 | F | 1 | B | N | > 3 | 5 | paracetamol | OCP |
| 10 | 29 | F | 13 | R | N | 1 | 2.5 | ibuprofen | zopiclone |
| 11 | 26 | F | 5 | R | N | 1 | 2 | aspirin, codeine, ibuprofen | OCP |
| 12 | 23 | F | 6 | R | N | 1 | 3–4 | ibuprofen | OCP |
| 13 | 23 | F | 10 | B | N | 0.5–1 | 4 | ibuprofen, codeine | OCP |
| 14 | 46 | F | 15–20 | B | N | 1 | 3 | sumatriptan | – |
| 15 | 41 | F | 40 | B | N | 2 | 4 | sumatriptan | – |
| 16 | 26 | M | 15 | B | N | > 3 | 2 | TCE, paracetamol, codeine | – |
| 17 | 23 | M | 3–4 | B | N | 0.5–1 | 3.5 | paracetamol, codeine | – |
| 18 | 23 | M | 4–5 | B | N | 0.5–1 | 4 | paracetamol | – |
| 19 | 55 | F | 40 | R | N | 0.5–1 | 3–4 | sumatriptan | telmisartan |
| 20 | 26 | M | 20 | R | N | 0.5–1 | 4 | metamizole | carbamazepine |
| 21 | 49 | F | 30 | B | N | 0.5–1 | 5 | rizatriptan, paracetamol | – |
| 22 | 27 | M | 4 | B | N | 0.5–1 | 4 | ibuprofen | SSRI |
| 23 | 28 | F | 25 | R | Y | 0.25 | 5 | ibuprofen, codeine | methylphenidate |
| 24 | 24 | F | 13 | R | Y | > 3 | 5 | TCL, paracetamol, codeine | – |
| 25 | 19 | F | 4–5 | B | N | > 3 | 3 | – | Lexapro, OCP |